1. Home
  2. CBC vs BLCO Comparison

CBC vs BLCO Comparison

Compare CBC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Bancompany Inc.

CBC

Central Bancompany Inc.

N/A

Current Price

$36.85

Market Cap

8.8B

Sector

N/A

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

N/A

Current Price

$19.53

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBC
BLCO
Founded
1902
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Ophthalmic Goods
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.1B
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
CBC
BLCO
Price
$36.85
$19.53
Analyst Decision
Hold
Buy
Analyst Count
5
15
Target Price
★ $36.30
$21.93
AVG Volume (30 Days)
867.8K
★ 980.7K
Earning Date
10-27-2026
10-28-2026
Dividend Yield
★ 1.50%
N/A
EPS Growth
★ 25.90
N/A
EPS
★ 1.42
N/A
Revenue
N/A
★ $5,101,000,000.00
Revenue This Year
$8.23
$7.83
Revenue Next Year
$5.79
$5.90
P/E Ratio
$26.20
★ N/A
Revenue Growth
N/A
★ 6.47
52 Week Low
$22.50
$14.65
52 Week High
$38.79
$21.40

Technical Indicators

Market Signals
Indicator
CBC
BLCO
Relative Strength Index (RSI) 54.45 47.83
Support Level $30.44 $15.30
Resistance Level $38.77 $21.38
Average True Range (ATR) 0.83 0.59
MACD -0.23 -0.16
Stochastic Oscillator 10.28 2.76

Price Performance

Historical Comparison
CBC
BLCO

About CBC Central Bancompany Inc.

Central Bancompany Inc is a bank holding company that provides a broad range of retail, corporate, mortgage banking, wealth management, and trust products and services to individuals and businesses. Its operating segments include Consumer, Commercial, and Wealth Management. The company generates the majority of its revenue from the Commercial segment, which provides full-service relationship banking solutions to businesses, agencies, and community organizations, including commercial, small business, and government clients. The segment also offers business payment solutions such as treasury management services, merchant services, and commercial bank card products.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.

Share on Social Networks: